Wikisage, the free encyclopedia of the second generation, is digital heritage

BIA 10-2474: Difference between revisions

From Wikisage
Jump to navigation Jump to search
mNo edit summary
No edit summary
 
Line 2: Line 2:


The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule [[gabapentine]] 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour
The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule [[gabapentine]] 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour
 
[[File:Bia102474 corrected.svg.png|miniature]]
[http://worldpediaen.wikia.com/wiki/BIA_10-2474?oldid=5467 Worldpedia BIA 10 2474]
[http://worldpediaen.wikia.com/wiki/BIA_10-2474?oldid=5467 Worldpedia BIA 10 2474]


{{Wikidata|Q22082929}}
{{Wikidata|Q22082929}}


[[Category:Clinical trial disasters]]
[[Category:Clinical trial disasters]]

Latest revision as of 14:26, 24 July 2019

In January 2016 an experimental study on a fatty acid amide hydrolase inhibitor of the type FIH, led to death of a healthy volunteer. A case of cummulative toxicity.

The molecule from Bial pharmaceutical company (Portela ca, Portugal) intended for enhancement of anandamide levels, its has a licking score (a formalin paw test) comparable to reference molecule gabapentine 300mg and 10 mg /Kg has a tail flick test maximum at 8 hour miniature Worldpedia BIA 10 2474

Q22082929 at Wikidata  Interwiki via Wikidata